Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGU

Optimal 68Ga-PSMA PET/CT imaging in assessment of prostate cancer: feasibility of only delayed acquisition using a total-body PET/CT scanner?

Xiaofeng Yu, Lian Xu, Jiajin Li, Ying Wang, Jianjun Liu and Yumei Chen
Journal of Nuclear Medicine August 2022, 63 (supplement 2) 2544;
Xiaofeng Yu
1Department of Nuclear Medicine, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lian Xu
1Department of Nuclear Medicine, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiajin Li
1Department of Nuclear Medicine, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ying Wang
1Department of Nuclear Medicine, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jianjun Liu
1Department of Nuclear Medicine, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yumei Chen
1Department of Nuclear Medicine, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

2544

Introduction: While dual-time point 68Ga-PSMA PET/CT could increase the lesion detection rate in PCa patients, it remains difficult to perform due to busy clinical service, the low count statistics and more radiation in delayed imaging. To prove that when performed on a total-body PET/CT, only one-time delayed acquisition of 68Ga-PSMA is feasible and provides increased lesion detection rate compared to standard acquisition. 

Methods: A retrospective clinical study between December 2020 and July 2021 was performed in 56 patients with PCa who had undergone 68Ga-PSMA-11 total-body PET/CT. All patients received a standard acquisition at 1 h p.i. and a late acquisition at 3 h p.i. . All images were obtained in a single bed position for 5 min on the total-body PET/CT. The image quality was qualitatively evaluated using a 5-point Likert scale. Lesions uptakes (SUVmax) and target-to-liver ratio (TLR) were compared using a Wilcoxon matched-pairs signed rank test, background uptakes (SUVmean) was compared using an Independent t test. And all lesions were further analyzed based on uptake values, sizes, types and sites.

Results: A total of 56 patients (mean age, 68&nbsp;±&nbsp;7 [standard deviation]) were enrolled in this study. The image quality was qualitatively assessed as modestly lower in the delayed imaging (3.4&nbsp;±&nbsp;0.5 at 3 h p.i.&nbsp;vs 4.8&nbsp;±&nbsp;0.2 at 1 h p.i.). The delayed images showed significantly increased PSMA-avid lesion&nbsp;uptake values (SUVmax)&nbsp;(median, 11.0 [range, 2.3 ~&nbsp;193.6] vs&nbsp;7.0&nbsp;[2.0&nbsp;~&nbsp;124.3], p&nbsp;<&nbsp;0.001) and elevated TLR (median, 3.3&nbsp;[range, 0.5&nbsp;~&nbsp;62.2]&nbsp;vs&nbsp;1.7 [0.3 ~ 30.7], p&nbsp;<&nbsp;0.001) compared to the standard images.&nbsp;The delayed images&nbsp;also presented reduced&nbsp;uptake values in most of the background regions (SUVmean). Delayed images provided additional lesion detection in 14 of 56 patients (25%), impacting management plans in 8&nbsp;of the 14 patients. Late acquisitions identified 9.7% additional PSMA-avid&nbsp;lesions&nbsp;(22/226) in the pelvic and extra-pelvic regions, 13&nbsp;of these 22 additional lesions were small lymph nodes (D&nbsp;<&nbsp;10mm) with significantly higher&nbsp;SUVmax&nbsp;and TLR.

Conclusions: Compared with the standard imaging, delayed imaging with 68Ga-PSMA-11 total-body PET/CT offered higher lesion uptake, reduced background uptake and improved lesion contrast. The additional findings in the delayed imaging provided a valuable information in the assessment of prostate cancer patients. The proposed protocol with only one-time acquisition of 5 min performed at 3 h p.i. is feasible in the clinical practice when performed on a total-body PET/CT system with an AFOV of 194 cm.

Acknowledgement:

This work was supported in part by the National Key Research&nbsp;and Development Program of China (Grant No. 2020YFA0909000), National Natural Science Foundation of China (Grant No.82102089), Construction Project of Shanghai Key&nbsp;Laboratory of Molecular Imaging (Grant No.&nbsp;18DZ2260400), and&nbsp;Shanghai Municipal Education Commission (Class II Plateau&nbsp;Disciplinary Construction Program of Medical Technology of SUMHS,&nbsp;2018&ndash;2020)

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
August 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Optimal 68Ga-PSMA PET/CT imaging in assessment of prostate cancer: feasibility of only delayed acquisition using a total-body PET/CT scanner?
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Optimal 68Ga-PSMA PET/CT imaging in assessment of prostate cancer: feasibility of only delayed acquisition using a total-body PET/CT scanner?
Xiaofeng Yu, Lian Xu, Jiajin Li, Ying Wang, Jianjun Liu, Yumei Chen
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2544;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Optimal 68Ga-PSMA PET/CT imaging in assessment of prostate cancer: feasibility of only delayed acquisition using a total-body PET/CT scanner?
Xiaofeng Yu, Lian Xu, Jiajin Li, Ying Wang, Jianjun Liu, Yumei Chen
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2544;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Semi-automatic Segmentation of Metastatic Tumor Load for 177Lu-PSMA Therapy
  • Can primary PET/CT staging using [68Ga]Ga-RM2 and [18F]Choline predict recurrence in prostate cancer?
  • Initial outcome of phase I study of Lu-177 Ludotadipep treatment in metastatic castration-resistant prostate cancer patients
Show more GU

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire